CH

CHEIL BIO CO., LTD.

Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.

052670 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기 안산시 목내동 456-2, 안산시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cheil Bio Co., Ltd. is a manufacturer of animal medicines and veterinary products focused on improving the health of livestock, aquatic animals, and pets. The company develops, produces, and distributes a wide range of pharmaceuticals, including antibiotics, nutritional supplements, probiotics, and functional feed additives. Leveraging its research and development capabilities, Cheil Bio aims to provide high-quality, technologically advanced solutions for the poultry, swine, cattle, and fishery sectors. The company is committed to achieving global technological competitiveness through continuous innovation in biotechnology.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CHEIL BIO CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 00:00
Share Issue/Capital Change
[기재정정]액면주식ㆍ무액면주식전환결정
Korean 16.9 KB
2025-09-15 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 31.6 KB
2025-09-10 00:00
Legal Proceedings Report
주요사항보고서(소송등의제기)
Korean 5.7 KB

Automate Your Workflow. Get a real-time feed of all CHEIL BIO CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CHEIL BIO CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea 217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea 038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea 256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Logo
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
Japan 4547
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.